Trial Profile
Phase II study of interleukin-2 and zoledronic acid as maintenance therapy in patients with multiple myeloma having undergone autograft
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 30 Jul 2012
Price :
$35
*
At a glance
- Drugs Aldesleukin (Primary) ; Zoledronic acid (Primary)
- Indications Bone metastases; Multiple myeloma
- Focus Therapeutic Use
- 02 Jun 2011 New trial record